2022
DOI: 10.1155/2022/1972516
|View full text |Cite|
|
Sign up to set email alerts
|

lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma

Abstract: Long noncoding RNAs (lncRNAs) stand as indispensable regulators of initiation and development in melanoma (melanoma). However, the action molecular mechanisms linked to melanoma remain unclear. In the current study, the findings revealed that AGAP2-AS1 was considerably greater in melanoma than in healthy tissues and that the level of AGAP2-AS1 in cancer tissue was significantly linked to the cancerous TNM stage of patients. Individuals with high AGAP2-AS1 had a considerably shorter survival duration than patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 37 publications
0
7
0
Order By: Relevance
“…For instance, An et al reported that AGAP2-AS1 was significantly higher in melanoma than in healthy tissues, and the researchers found that the level of AGAP2-AS1 in cancer tissues was significantly connected to the TNM stage of the patient's malignancy. Individuals who had a high level of AGAP2-AS1 had a survival duration that was noticeably lower than that of patients who had a low level of AGAP2-AS1, and this was true for both progression-free survival and overall survival [ 31 ]. In melanoma, inhibiting the expression of the long noncoding RNA AGAP2-AS1 has the functional effect of reducing carcinogenesis and ferroptosis resistance via the SLC7A11-IGF2BP2 pathway.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, An et al reported that AGAP2-AS1 was significantly higher in melanoma than in healthy tissues, and the researchers found that the level of AGAP2-AS1 in cancer tissues was significantly connected to the TNM stage of the patient's malignancy. Individuals who had a high level of AGAP2-AS1 had a survival duration that was noticeably lower than that of patients who had a low level of AGAP2-AS1, and this was true for both progression-free survival and overall survival [ 31 ]. In melanoma, inhibiting the expression of the long noncoding RNA AGAP2-AS1 has the functional effect of reducing carcinogenesis and ferroptosis resistance via the SLC7A11-IGF2BP2 pathway.…”
Section: Discussionmentioning
confidence: 99%
“…AGAP2 antisense RNA 1 (AGAP2-AS1) is a lincRNA that was first found overexpressed in human NSCLC, being also implicated in other malignant diseases such as colorectal cancer and melanoma [161][162][163]. By interacting with specific RNA-binding proteins, namely enhancers of zeste 2 polycomb repressive complex 2 subunit (EZH2) and LSD1, some lncRNAs can regulate cell phenotypes.…”
Section: Agap2-as1mentioning
confidence: 99%
“…These findings reveal the important role of miRNA in regulating ferroptosis in MM. Increased expression of the lncRNA AGAP2-AS1 promotes tumorigenesis by promoting ferroptosis evasion through increased SLC7A11 mRNA stability by the m 6 A modification in an IGF2BP2-dependent manner in MM ( An et al, 2022 ). AGAP2-AS1 functions as an oncogene in MM, and its increased expression is known to be significantly associated with a poor prognosis ( An et al, 2022 ).…”
Section: The Role Of Ferroptosis In Melanomamentioning
confidence: 99%